Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Oct 22;97(8):1135-8.
doi: 10.1038/sj.bjc.6604001. Epub 2007 Oct 16.

Low density of CD3+, CD4+ and CD8+ cells is associated with increased risk of relapse in squamous cell cervical cancer

B S Nedergaard  1 , M Ladekarl, H F Thomsen, J R Nyengaard, K Nielsen
Affiliations

Low density of CD3+, CD4+ and CD8+ cells is associated with increased risk of relapse in squamous cell cervical cancer

B S Nedergaard et al. Br J Cancer. .

Abstract

The purpose of this study was to investigate the prognostic value of the primary in situ cellular immune response in cervical squamous cell carcinoma. A study of 102 women treated for stage IB and IIA disease, between 1990 and 2000, was performed. Paraffin-embedded cervical tissue processed at the time of diagnosis was immunostained for CD3+ (T cells), CD4+ (T helper/regulatory T cells) and CD8+ (cytotoxic T cells) cells. Immune cell profile densities were estimated using stereology. Both intra- and peritumoural cell densities were estimated. Using Cox's proportional hazards regression modelling we found an increase in cell density to decrease the risk of relapse for all three cell types. The density of peritumoural CD3+ cells seems to have the strongest potential for predicting relapse. An increase in CD3+ cell density from 795 to 2043 cells per mm(2) (25-75 percentile) reduced the hazard ratio to 0.27.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Relapse-free survival in stage IB-IIA shown for each quartile of density of peritumoural CD3+ cells.
See this image and copyright information in PMC

References

    1. Benedet JL, Bender H, Jones III H, Ngan HY, Pecorelli S (2000) FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet 70(2): 209–262 - PubMed
    1. Bethwaite PB, Holloway LJ, Thornton A, Delahunt B (1996) Infiltration by immunocompetent cells in early stage invasive carcinoma of the uterine cervix: a prognostic study. Pathology 28: 321–327 - PubMed
    1. Bosch FX, Munoz N (2002) The viral etiology of cervical cancer. Virus Res 89: 183–190 - PubMed
    1. Chao HT, Wang PH, Tseng JY, Lai CR, Chiang SC, Yuan CC (1999) Lymphocyte-infiltrated FIGO Stage IIB squamous cell carcinoma of the cervix is a prominent factor for disease-free survival. Eur J Gynaecol Oncol 20: 136–140 - PubMed
    1. Dupont G, Lauszus FF, Guttorm E, Vetner MO (2005) [Survival rate after radical hysterectomy for cervical cancer performed in a central hospital]. Ugeskr Laeger 167: 4367–4371 - PubMed

Publication types

MeSH terms